OncoZenge AB (publ)

ONCOZ.ST

Biotechnology · Healthcare

Exchange

Stockholm Stock Exchange

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

OncoZenge is a small Swedish biotech company focused on reducing mouth pain caused by cancer treatments. Its main product is BioErodible MucoAdhesive (BEMA) technology delivered as a dissolving disc placed inside the mouth to treat oral mucositis — a painful side effect of chemotherapy and radiation that affects cancer patients. The company targets oncology clinics and cancer patients, primarily in Europe.

OncoZenge earns revenue through drug development and potential licensing or commercialization of its BEMA-based treatments, though it is not yet generating meaningful commercial sales. It operates mainly in Sweden and is a very early-stage company, reflected in its deeply negative operating margin and small market cap of around $100 million. The key risk is straightforward: the company depends almost entirely on clinical trial success and regulatory approval to survive, and without additional funding or a partnership deal, it faces significant financial pressure in the near term.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

<−1,000% YoY

YoY Growth Rate

Earnings declining

Insider Activity

45.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

kr 935,000 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

OncoZenge AB (publ) has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

Data not available

Profit after running costs

Operating Margin

N/A

Data not available

Return on the money invested

ROCE

-288.0%

Weak — -288.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-95.7%

Shrinking sales (-95.7% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-29400.0%

Burning cash (-29400.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

20.95

Heavy debt load (20.95)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial